 Mediplacements |
Asthma drug 'almost eliminates seasonal attacks'
Mediplacements Research published in the New England Journal of Medicine found that Xolair (omalizumab) improved asthma control, almost eliminated seasonal episodes and lessened the need for controller medication. Asthmatic children who received the drug experienced … |
View full post on asthma – Google News